New year, new you! Check out our at-home lab tests Shop Now

Men's Premium Panel (Comprehensive Wellness Panel for Men)

This comprehensive wellness panel for men measures four biomarkers in the blood to provide an overall view of the health. Combined with the vascular screening results, this men’s wellness panel provides a deeper level of understanding regarding risk for chronic disease.

$149.00
Schedule this Screening
*Screening availability may be limited by location.

What this Comprehensive Wellness Panel for Men Will Tell You

This comprehensive wellness panel for men analyzes your blood to help you understand your risk for kidney disease, cardiovascular disease, diabetes, and prostate cancer.

  • The men’s kidney function blood test measures creatinine level, as well as the rate blood is filtered through the kidneys (called eGFR). Creatinine is a waste product filtered out by the kidneys. Elevated levels of creatinine might indicate that the kidneys are not functioning as well as they should to filter waste.
  • Men’s prostate cancer screening: despite clear evidence that PSA testing has contributed to lowering the death rate from prostate cancer3, PSA testing by itself is not an indication of cancer. There are other conditions that can cause elevated PSA levels, including an enlarged prostate or infection. Higher than expected PSA levels in the blood will most likely lead to your physician taking additional steps including a complete physical examination.
  • Men’s glucose level (A1c) screening measures average glucose (blood sugar) level over the previous 2-3 months, which is an indicator for diabetes risk.
  • Men’s C-Reactive protein screening measures the level of C-reactive protein in the blood. Higher than normal CRP levels indicates possible inflammation in the body, which can be a marker for cardiovascular disease.

About The Conditions Included in the Men’s Wellness Panel

  • Chronic Kidney Disease (CKD) affects approximately 14% of people in the U.S., and the primary causes are diabetes and high blood pressure. Kidney disease will often develop without any symptoms. Each year, kidney disease kills more people than breast or prostate cancer.1 Click here to review the risk factors for kidney disease.
  • Prostate cancer is a common cancer in men. The prostate-specific antigen (PSA) test measures the level of PSA in the blood. Elevated levels of PSA in the blood could indicate indicate an infection or an enlarged prostate instead of cancer. PSA testing is only the first step when prostate cancer is possible, so please discuss your screening results with your doctor. Click here to review the risk factors for prostate cancer.
  • A1c screening is the most widely used screening for diabetes risk. Diabetes occurs when the body does not produce or properly use insulin (the hormone that converts food into energy). The most common type of diabetes is Type 2, in which the body does not use insulin properly, called insulin resistance.

Diabetes is widespread—9% of adults in the U.S. have diabetes, and over 20% are not aware they have it.1 Diabetes puts people at a higher risk for stroke, heart disease, vision decline, and circulation problems. With a simple finger-stick blood sample, you can understand your risk for developing diabetes. Click here to review the risk factors for diabetes.

  • C-Reactive protein, a by-product of inflammation in the body, has been linked to heart disease. When plaque forms in the arteries, it causes injury to the arteries, releasing
    C-Reactive protein into the blood. A CRP screening helps to evaluate a person’s overall risk for cardiovascular disease. Risk factors for cardiovascular disease include diabetes, high cholesterol, high blood pressure, obesity, smoking, and a family history of stroke or heart disease.

Wellness Panel Premium-Men Screening Details

  • Kidney function results will indicate the creatinine level in your blood as well as the eGFR (Estimated Glomerular Filtration Rate), which is the rate that blood is passing through the kidneys.
  • The prostate cancer test is a finger-stick blood sample used to measure the amount of prostate-specific antigen (PSA) in the blood. Your prostate testing results will indicate if the PSA level in your blood is normal or abnormal for your age group, and will also indicate if you should see your personal physician about your PSA test results.
  • The A1c screening measures the average blood sugar level for the past two to three months. The American Diabetes Association recommends that the A1c test be the primary screening tool used to diagnose prediabetes, type 1 diabetes, and type 2 diabetes.
  • The high-sensitivity C-reactive protein screening detects even small changes in the C-reactive protein levels in the blood. This is important when evaluating a person’s overall risk for developing cardiovascular disease.

Wellness Panel Premium-Men Screening Details

  • Kidney function results will indicate the creatinine level in your blood as well as the eGFR (Estimated Glomerular Filtration Rate), which is the rate that blood is passing through the kidneys.
  • The prostate cancer test is a finger-stick blood sample used to measure the amount of prostate-specific antigen (PSA) in the blood. Your prostate testing results will indicate if the PSA level in your blood is normal or abnormal for your age group, and will also indicate if you should see your personal physician about your PSA test results.
  • The A1c screening measures the average blood sugar level for the past two to three months. The American Diabetes Association recommends that the A1c test be the primary screening tool used to diagnose prediabetes, type 1 diabetes, and type 2 diabetes.
  • The high-sensitivity C-reactive protein screening detects even small changes in the C-reactive protein levels in the blood. This is important when evaluating a person’s overall risk for developing cardiovascular disease.

References

1. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 2017,https://www.niddk.nih.gov/health-information/communication-programs/nkdep/identify-manage-patients/evaluate-ckd

2. Centers for Disease Control, https://www.cdc.gov/media/releases/2017/p0718-diabetes-report.html

3. American Society of Clinical Oncology, cancer.net, January 2019, https://www.cancer.net/cancer-types/prostate-cancer/statistics